GeneBio Systems
Recombinant Human LIMP-2/LIMPII Protein (His & Fc Tag)
Recombinant Human LIMP-2/LIMPII Protein (His & Fc Tag)
SKU:PKSH031285
Couldn't load pickup availability
Size: 100μg
Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping: This product is provided as lyophilized powder which is shipped with ice packs.
Exp date: 12 months
Category ID_II: Recombinant Proteins
Category ID_III: Others
Abbreviation:
Target Synonym: 85 kDa Lysosomal Membrane Sialoglycoprotein;AMRF;CD36;CD36 Antigen-Like 2;CD36L2;EPM4;HLGP85;LGP85;LIMP II;LIMPII;Lysosome Membrane Protein 2;Lysosome Membrane Protein II;SCARB2;SR-BII;Scavenger Receptor Class B Member 2
Research Areas: Signal Transduction;Cardiovascular;Cancer;metabolism;
Conjugation:
Target Species: Human
Expression Host: HEK293 Cells
Application: ELISA
Fusion tag: C-His-Fc
UNIProt ID: Q14108
Accession: NP_005497.1
Background: Lysosomal Integral Membrane Protein II (LIMPII), also known as SCARB2, LPG85, and CD36L2, is a type III multi-pass membrane glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes on all tissues and cell types so far examined. This protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. LIMPII is identified as a receptor for EV71 (human enterovirus species A, Enterovirus 71) and CVA16 (coxsackievirus A16) which are most frequently associated with hand, foot and mouth disease (HFMD). Expression of human LIMPII enables normally unsusceptible cell lines to support the viruses’ propagation and develop cytopathic effects. In addition, LIMPII also has been shown to bind thrombospondin-1, may contribute to the pro-adhesive changes of activated platelets during coagulation, and inflammation. Deficiency of the protein in mice impairs cell membrane transport processes and causes pelvic junction obstruction, deafness, and peripheral neuropathy.
Concentration:
Activity: Measured by its ability to bind recombinant human RSPO1 in a functional ELISA.
Sequence: Arg 27-Thr 432
Purity: > 90 % as determined by reducing SDS-PAGE.
Formulation: Lyophilized from sterile PBS, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution: Please refer to the printed manual for detailed information.
Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
Calculated MW: 74.4 kDa
ObservedMW: 110-115 kDa
